Thompson Davis & Co., Inc. Athersys, Inc Transaction History

Thompson Davis & Co., Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$0.85 - $1.4 $12,056 - $19,857	-14,184 Closed	0 $0
Q2 2018 Aug 03, 2018	SELL	$1.76 - $2.79 $4,400 - $6,975	-2,500 Reduced 14.98%	14,184 $28,000
Q1 2018 May 02, 2018	SELL	$1.34 - $2.03 $40,225 - $60,938	-30,019 Reduced 64.28%	16,684 $31,000
Q4 2017 Feb 05, 2018	SELL	$1.65 - $2.45 $29,040 - $43,120	-17,600 Reduced 27.37%	46,703 $85,000
Q3 2017 Oct 30, 2017	BUY	$1.5 - $2.55 $85,024 - $144,541	56,683 Added 743.87%	64,303 $132,000
Q2 2017 Aug 10, 2017	BUY	N/A	7,620	7,620 $12,000

Ticker ATHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 305,110,016
Market Cap $3.05M
Description
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...

Get notified when there are updates to the investment portfolio of Thompson Davis & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on Thompson Davis & Co., Inc. with notifications on news.